Health News Releases

  • Today December 21
August 25, 2017 16:35
19 Healthcare Organizations in Taiwan Make Commitments Toward Zero Preventable Patient Deaths
The Patient Safety Movement Foundation (PSMF) announced today that 19 hospitals and healthcare organizations in Taiwan have signed a commitment to implement processes to eliminate preventable patient
August 25, 2017 15:55
GRAMINEX L.L.C. Opens New Office in Seoul, Korea, Graminex Korea Co., Ltd.
Graminex® LLC, producer of Graminex® Flower Pollen Extracts™, is pleased to announce the opening of Graminex® Korea Co., Ltd. Sun-Ho Frank Kim, Ph.D. has been appointed Managing Director of the local
August 24, 2017 17:50
Herbalife Nutrition Extends Title Sponsorship for Bali International Triathlon 2017
Global nutrition company, Herbalife has been named as the title sponsor of the Bali International Triathlon for the third consecutive year. Called the Herbalife Bali International Triathlon 2017, the
August 24, 2017 11:55
GN Hearing Announces Availability of Rechargeable Solution for the Recently Launched ReSound LiNX 3D
GN Hearing introduces a rechargeable battery option for the revolutionary ReSound LiNX 3D hearing aids. Available in North America and other major markets from September 1, the rechargeable battery so
August 24, 2017 10:55
Publication of Clinical Data Demonstrating Low Immunogenicity and Excellent Efficacy of Nuwiq® in Previously Untreated Patients
Octapharma is delighted to announce the publication of interim data from the NuProtect study (GENA-05, NCT01712438), the first clinical data on treatment with Nuwiq® in previously untreated patients (
August 22, 2017 15:20
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform
Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative
August 22, 2017 13:25
Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuo
August 21, 2017 16:37
Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 2017
Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In t
August 14, 2017 17:15
Dubai Health Authority Implements Masimo Patient SafetyNet™
Masimo (NASDAQ:MASI) announced today that the Dubai Health Authority (DHA), the government organization that oversees the healthcare systems of Dubai, is augmenting its current inventory of Masimo equ
August 10, 2017 11:15
noUV Announces Totally New Way to Protect Human Bodies from Harmful UV Rays Using Extract from Ferns
noUV Inc., a health and beauty care supplement company, has created “noUV,” an orally ingestible sunscreen supplement as a totally new way to protect the body from harmful effects of the sun’s ultravi
August 09, 2017 19:00
FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer
WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start the clinical investigation of a novel therapeutic approach using a combination of three targeted therapies f
August 08, 2017 14:00
Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the performance of Masimo SpHb®, noninvasive, continuous he
August 04, 2017 17:15
Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run
Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that signifi
August 03, 2017 13:45
Takeda Reports 1st Quarter FY2017 Results
Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda's Growth Drivers · Underlying Revenue grew +6.6% with growth across all regions (U.S. +13.5%,
August 02, 2017 14:55
Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenAid® and Prostanex®
Graminex® LLC, producer of Graminex® Flower Pollen Extracts™, receives Health Canada Approval under the Natural and Non-prescription Health Products Directorate (NNHPD) for its PollenAid® and Prostane
August 01, 2017 13:25
Study Compares Performance of Masimo Acoustic Respiration Rate (RRa®) and Nellcor Plethysmographic Respiration Rate in Volunteers
Masimo (NASDAQ: MASI) announced today that researchers at the Tokyo Women’s Medical University, Department of Anesthesiology, in Japan have published a study investigating the measurement of respirati
July 28, 2017 10:30
Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA®
Boehringer Ingelheim announced today that the first patient has been enrolled into its VOLTAIRE-X interchangeability study. The goal of the study is to demonstrate that BI 695501 is interchangeable wi
July 28, 2017 09:40
Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV
Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommendin
July 24, 2017 18:10
Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen
Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced that a regimen of two investigational long-acting, injectable formulations of HI
July 24, 2017 18:05
Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine
Johnson & Johnson today announced encouraging first-in-human clinical data for an investigational HIV-1 vaccine regimen in development at its Janssen Pharmaceutical Companies. In an oral presentation
July 24, 2017 17:55
People with idiopathic pulmonary fibrosis (IPF) reveal high burden of disease in new survey
New results from a global survey supported by Boehringer Ingelheim[1] reveal the emotional and practical challenges facing people with idiopathic pulmonary fibrosis (IPF). Patients are impacted by fee
July 24, 2017 09:00
Mannatech Korea Introduces the Most Advanced Ginseng Supplement in the World
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, has launched GinMAX™ tablets in its Korea market. GinMAX is a powe
July 21, 2017 13:45
Masimo Announces CE Marking of Noninvasive RPVi™, a rainbow® Multi-Wavelength Index of Pleth Variability
Masimo (NASDAQ: MASI) announced today the CE marking of RPVi™, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during one or more respiratory cycles.
July 17, 2017 11:45
PSMF Convenes the International Patient Safety Community for its 2017 Midyear Planning Meeting at Inova Center for Personalized Health
The Patient Safety Movement Foundation (PSMF) brought together over 100 medical care providers, hospital administrators, and patient safety experts and advocates to discuss ongoing challenges and refi
July 17, 2017 09:00
Mannatech Korea Makes the Morning Healthier with New Nutrient-Rich Coffee
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, recently launched the world’s most complete coffee, GlycoCafé™, to
25 per page50 per page75 per page100 per page